David S. Connor

Founder Rare Disease Data Trust, 30 years in Bio-pharma, Novartis, Shire, Aegerion, Viropharma, Pharmion, Merck, RPR, Guilford, Pharmion, MTPA, Schering-Plough. Commercially launched seven first to market, first in therapy rare disease therapies